UK markets open in 41 minutes
NIKKEI 225
28,526.66 +707.33 (+2.54%) HANG SENG
20,182.55 +100.12 (+0.50%) CRUDE OIL
94.01 -0.33 (-0.35%) GOLD FUTURES
1,807.50 +0.30 (+0.02%) DOW
33,336.67 +27.16 (+0.08%) BTC-GBP
19,634.12 -601.11 (-2.97%)
NVAX Jan 2024 210.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:26PM EDT. Market open.
| Previous close | 158.78 |
| Open | 158.79 |
| Bid | 159.35 |
| Ask | 165.70 |
| Strike | 210.00 |
| Expiry date | 2024-01-19 |
| Day's range | 158.78 - 158.79 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
- Simply Wall St.
These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts
The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...
- Zacks
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
- Motley Fool
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
This year hasn't been an easy one for Novavax (NASDAQ: NVAX) investors. After a series of stumbles culminating in its disastrous earnings report on Aug. 8, its shares are down by 60% so far in 2022. And with management slashing its full-year revenue guidance by roughly half, there isn't much hope for smoother sailing for at least a few quarters.
© 2022 Yahoo. All rights reserved.
